In case of CKD, the use of a GLP-1RA with proven cardiovascular benefit is only recommended in those who have not achieved individualized glycemic targets despite SGLT2i treatment, or in whom SGLT2is are contraindicated or not tolerated [6, 8]
Semaglutide mimics the natural hormone GLP-1, playing a crucial role in regulating appetite and food intake
Purpose-built for physicians Glucose-lowering therapies may reduce risk for dementia, but more research needed Key takeaways: Two research teams found that GLP-1 receptor agonists reduced dementia risk, but results differed regarding SGLT2 inhibitors
The goal is to support your body with the right basics: protein, hydration, digestion, muscle maintenance, and consistency
Once the data is sufficiently acceptable the cost-benefit analysis for the insurers is impossible to ignore they will begin covering these drugs widely, and the benefit to the patients will show up in terms of savings
Aetna updates them every quarter
:max_bytes(150000):strip_icc()/GettyImages-1299286851-18ab6e02931940ad963dda93851b6dc7.jpg)
